» Authors » Andreas Voss

Andreas Voss

Explore the profile of Andreas Voss including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 471
Citations 7500
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Refisch A, Schumann A, Gupta Y, Schulz S, Voss A, Malchow B, et al.
Schizophrenia (Heidelb) . 2025 Mar; 11(1):40. PMID: 40057504
Underlying biological mechanisms leading to the dramatically increased cardiac mortality in patients with schizophrenia (SCZ) are largely unknown. Cardiac autonomic dysfunction (CADF), which has been extensively described in patients with...
2.
Cimen C, Voss A, Hellkamp J, Hamprecht A, Berends M
J Glob Antimicrob Resist . 2025 Mar; PMID: 40054523
Objectives: To analyse the trends in occurrence of enterococcal and vancomycin-resistant Enterococcus faecium (VREfm) bacteraemia in the northern Dutch-German cross-border region. Methods: A retrospective cross-sectional study was conducted using positive...
3.
Schulz S, Schumann A, Bar K, Haueisen J, Seifert G, Voss A
Front Neurosci . 2025 Feb; 19:1504161. PMID: 40018361
The detection and quantification of coupling strength and direction are important aspects for achieving a deeper understanding of physiological regulatory processes in the field of network physiology. Due to the...
4.
Stump A, Wustenberg T, Rouder J, Voss A
Cogn Affect Behav Neurosci . 2025 Feb; PMID: 40011403
People tend to judge repeated information as more likely true compared with new information. A key explanation for this phenomenon, called the illusory truth effect, is that repeated information can...
5.
Cimen C, Berends M, Lokate M, Glasner C, Herrmann J, Bathoorn E, et al.
Antimicrob Resist Infect Control . 2025 Feb; 14(1):11. PMID: 39940037
Infections due to multidrug-resistant organisms (MDROs) are a health threat due to increasing patient morbidity and mortality and the burden on healthcare systems. Robust infection prevention and control (IPC) measures...
6.
Lang F, Voss A, Kobbe G, Junghanss C, Beck J, Viardot A, et al.
Leuk Lymphoma . 2025 Feb; :1-9. PMID: 39921529
Imatinib (IMA) plus chemotherapy followed by allogeneic hematopoietic cell transplantation (HCT) is established treatment for Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). We investigated the use of dasatinib (DASA)...
7.
Meijer E, Marek A, Ramage G, Chowdhary A, Bagrade L, Voss A, et al.
Med Mycol . 2025 Jan; 63(2). PMID: 39875195
Invasive mould disease (IMD) has a high mortality in immunosuppressed patients. Invasive aspergillosis (IA) is the most common IMD. A guideline for preventing IA has been published jointly by the...
8.
Shahswar R, Gabdoulline R, Krueger K, Wichmann M, Gotze K, Braitsch K, et al.
Leukemia . 2025 Jan; 39(3):614-622. PMID: 39779979
Off-label hypomethylating agents and venetoclax (HMA/VEN) are often used for relapsed and refractory (R/R) AML patients. However, predictors of outcome are elusive. The objective of the current retrospective observational multicenter...
9.
Greiner S, Voss A, Soler A, Bhayana H
Arch Orthop Trauma Surg . 2024 Dec; 145(1):62. PMID: 39694925
Purpose: Varus posteromedial rotatory instability (VPMRI) involves anteromedial coronoid fracture (AMCF), lateral ulnar collateral ligament (LUCL), and medial collateral ligament (MCL) injury. There is no general consensus regarding the surgical...
10.
Metzner B, Muller T, Casper J, Kimmich C, Petershofen E, Thole R, et al.
Eur J Haematol . 2024 Dec; 114(3):536-544. PMID: 39655760
Background: Secondary malignancies are potential complications after high-dose therapy and autologous stem cell transplantation (ASCT). Information on the detailed course of such events is scarce, yet may be essential to...